Bylvay 400 ug/1 (Odevixibat CAPSULE) 400 ug/1

Bylvay 400 ug/1 is a medication used to manage specific liver-related conditions. This oral capsule, manufactured by Ipsen Biopharmaceuticals, Inc., contains the active ingredient odevixibat. Learn more about its uses and effects.

Strength

400 ug/1

Pack Size

1 BOTTLE in 1 CARTON (15054-3302-1) / 30 CAPSULE in 1 BOTTLE

Manufacturer / TM Owner

Ipsen Biopharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Bylvay 400 ug/1 is primarily used to address certain liver disorders. Odevixibat, the active ingredient, is designed to help manage conditions that affect bile flow. This medication is often prescribed for patients who require support in maintaining liver function. Understanding what is Bylvay used for can help patients and caregivers make informed decisions about treatment options.

Side Effects

Common effects of Bylvay 400 ug/1 may include changes in bowel movements and digestive comfort. Some users might experience mild gastrointestinal symptoms as their body adjusts to the medication. It's important to monitor any persistent or severe effects and consult a healthcare provider if necessary.

Precautions & Warnings

Bylvay 400 ug/1 should be handled with care, following the prescribed dosage and administration guidelines. Store the medication in a cool, dry place away from direct sunlight. Always follow the instructions provided by your healthcare provider to ensure safe and effective use.

Avoid Interactions

Bylvay 400 ug/1 may interact with certain medications, including those that affect liver function or bile flow. It's important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances that affect the liver should be consumed with caution.

Frequently Asked Questions

Bylvay is used to manage specific liver-related conditions, particularly those affecting bile flow.

Bylvay 400 ug/1 is taken orally, typically as directed by a healthcare provider.

Common side effects may include changes in bowel movements and mild gastrointestinal discomfort.

Bylvay may be available for purchase online from authorized pharmacies.

If you miss a dose, consult your healthcare provider for guidance on when to take the next dose.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.